Cure8 research brief
Researchers link a bacterial metabolic pathway (pdu/pduB) in AIEC to intestinal inflammation and show that host vitamin B12 availability can reduce bacterial invasion and colitis in mice—suggesting a modifiable host factor that might be relevant to AIEC-associated Crohn's disease.
Researchers studying the microbiome and IBD, clinicians interested in Crohn's disease pathogenesis, and patients or advocates following microbiome-driven research.
This paper (abstract) reports that a gene in the 1,2-propanediol utilization (pdu) pathway—specifically pduB—in adherent-invasive E. coli (AIEC) is required for epithelial invasion and for driving colitis in multiple mouse models.
Deleting pduB reduced mucosal association, lowered pro-inflammatory cytokine expression, and protected against epithelial barrier dysfunction in mice.
The authors found host vitamin B12 levels changed during infection and that giving extra vitamin B12 reduced AIEC invasion in vitro and strongly protected mice from AIEC-induced colitis, suggesting that vitamin B12 availability alters AIEC virulence through the pdu pathway.
These results come from laboratory and mouse-model experiments reported in the article abstract; they demonstrate a microbe–nutrient interaction that could point toward new therapeutic strategies but are preclinical and not clinical recommendations.
This is an abstract/summary of basic-science work in mice and cell models. It identifies a promising mechanism but does not provide clinical evidence that vitamin B12 supplementation will benefit people with Crohn's disease.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The work links climate and sociodemographic context to IBD burden in tropical regions, which can influence diagnostic recognition, resource needs, and research priorities for communities where IBD is rising.
The findings point to an immune-cell change that may happen before Crohn’s symptoms appear, which could help predict relapse or guide future therapies. That could eventually affect monitoring or new treatment strategies...
This study explores genetic risk variants (NOD2/CARD15) and local environmental factors (khat use) among young adults with IBD in Djibouti — information that may help explain regional differences in Crohn’s disease and...
